Clinical case of a patient with fatal development of gas gangrene while using totally implantable venous access devices.

Abstract

Gas gangrene, or clostridial myonecrosis, is a rare and life-threatening infection caused primarily by Clostridiumperfringens. Despite its reduced incidence due to advancements in wound care and antibiotics, the disease remains associated with significant morbidity and mortality, particularly in immunocompromised individuals. This report presents a clinical case of a 37-year-old male with esophageal carcinoma and a totally implantable venous access device (Port-a-Cath), who developed fatal gas gangrene following chemotherapy.